ESLICARBAZEPINE ACETATE
NDC 59651-533, ESLICARBAZEPINE ACETATE, tablet, from Aurobindo Pharma Limited.
- Product NDC
- 59651-533
- Status
- Listed
- Labeler
- Aurobindo Pharma Limited
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA216481
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/59651-533 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ESLICARBAZEPINE ACETATE200 mg/1
Pharmacologic classes
Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 59651-533-30 | 59651053330 | 30 TABLET in 1 BOTTLE (59651-533-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/2067fb77-9657-44da-b430-02e8a4efacb5NADAC price for package 59651053330
GET /v1/drugs/nadac/59651053330
Use it
Look up 59651-533 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/59651-533 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 59651-533. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.